[Immunotherapy study in the treatment of metastatic renal cancer in the adult].

@article{Philip1992ImmunotherapySI,
  title={[Immunotherapy study in the treatment of metastatic renal cancer in the adult].},
  author={Thierry Philip and Sylvie N{\'e}grier},
  journal={Bulletin de l'Academie nationale de medecine},
  year={1992},
  volume={176 6},
  pages={873-7; discussion 877-8}
}
Metastatic renal cancer is one of the models used for immunotherapy study. Interleukin-2 is active in this chemo and radioresistant tumour and induces the regression of diffuse metastatic lesions sometimes completely through the activation of the immune system. Interleukin-2 has also led to the development of new therapeutic approaches in oncology such as… CONTINUE READING